Patient Portal

Marin H. Kollef, MD, FACP, FCCP

Professor, Medicine
Division of Pulmonary and Critical Care Medicine
Director, Medical Intensive Care Unit, Barnes-Jewish Hospital
Director, Respiratory Care Services, Barnes-Jewish Hospital

Specialty Areas

Pulmonary Disease
Critical Care Medicine

Board Certifications

Pulmonary Disease
Internal Medicine
Critical Care Medicine

Hospital Affiliations

Barnes-Jewish Hospital

Referral Information

Professional Consultation Only

Areas of Clinical Interest

Critical care medicine, pneumonia, emphysema,

  • Maps & Directions
  • Education
  • Publication & Research
  • Financial Disclosures

Maps & Directions

Maps & Directions

Barnes-Jewish Hospital

1 Barnes-Jewish Hospital Plaza
St. Louis, MO 63110

Education

Education

Fellowship: Fred Hutchinson Cancer Institute, Seattle, Washington; Bone Marrow Transplant Critical Care Service 1988
Fellowship: Pulmonary Disease and Critical Care, Madigan Army Medical Center, Tacoma, Washington 1988
Residency: Internal Medicine, Madigan Army Medical Center, Tacoma, Washington 1986
Medical Degree: University Of Rochester, Rochester, New York 1983

Publication & Research

Publication & Research

Antibiotic Thresholds for Sepsis and Septic Shock.
Kollef MH, Burnham JP
Clin Infect Dis. 2018 Dec 7; doi: 10.1093/cid/ciy1035.

PMID:
    30535353
    [PubMed - as supplied by publisher]
Related citations


Duration of Exposure to Antipseudomonal β-Lactam Antibiotics in the Critically Ill and Development of New Resistance.
Teshome BF, Vouri SM, Hampton N, Kollef MH, Micek ST
Pharmacotherapy. 2018 Dec 3; doi: 10.1002/phar.2201.

PMID:
    30506852
    [PubMed - as supplied by publisher]
Related citations


The carbon footprint of treating patients with septic shock in the intensive care unit.
McGain F, Burnham JP, Lau R, Aye L, Kollef MH, McAlister S
Crit Care Resusc. 2018 Dec; 20(4)304-312.

PMID:
    30482138
    [PubMed - in process]
Related citations


Re-estimating annual deaths due to multidrug-resistant organism infections.
Burnham JP, Olsen MA, Kollef MH
Infect Control Hosp Epidemiol. 2018 Nov 22; 1-2. doi: 10.1017/ice.2018.304.

PMID:
    30463634
    [PubMed - as supplied by publisher]
Related citations


Is Zero Ventilator-Associated Pneumonia Achievable?: Practical Approaches to Ventilator-Associated Pneumonia Prevention.
Vazquez Guillamet C, Kollef MH
Clin Chest Med. 2018 Dec; 39(4)809-822. doi: 10.1016/j.ccm.2018.08.004.

PMID:
    30390751
    [PubMed - in process]
Related citations


Protocol for a multicentre, prospective cohort study of practice patterns and clinical outcomes associated with emergency department sedation for mechanically ventilated patients: the ED-SED Study.
Fuller BM, Mohr NM, Roberts BW, Carpenter CR, Kollef MH, Avidan MS
BMJ Open. 2018 Oct 21; 8(10)e023423. doi: 10.1136/bmjopen-2018-023423.

PMID:
    30344178
    [PubMed - in process]
Related citations


Catheter removal and outcomes of multidrug-resistant central-line-associated bloodstream infection.
Burnham JP, Rojek RP, Kollef MH
Medicine (Baltimore). 2018 Oct; 97(42)e12782. doi: 10.1097/MD.0000000000012782.

PMID:
    30334966
    [PubMed - indexed for MEDLINE]
Related citations


The most recent concepts for the management of bacterial and fungal infections in ICU.
Bassetti M, Poulakou G, Kollef MH
Intensive Care Med. 2018 Nov; 44(11)2000-2003. doi: 10.1007/s00134-018-5400-9.

PMID:
    30293148
    [PubMed - in process]
Related citations


Postoperative Pneumonia Prevention in Pulmonary Resections: A Feasibility Pilot Study.
Semenkovich TR, Frederiksen C, Hudson JL, Subramanian M, Kollef MH, Patterson GA, Kreisel D, Meyers BF, Kozower BD, Puri V
Ann Thorac Surg. 2018 Oct 3; pii: S0003-4975(18)31350-X. doi: 10.1016/j.athoracsur.2018.08.008.

PMID:
    30291834
    [PubMed - as supplied by publisher]
Related citations


Response.
Shorr AF, Kollef MH
Chest. 2018 Jul; 154(1)224. doi: 10.1016/j.chest.2018.02.028.

PMID:
    30044736
    [PubMed - in process]
Related citations


Diagnosis and Treatment of Acute Respiratory Distress Syndrome.
Fuller BM, Mohr NM, Kollef MH
JAMA. 2018 Jul 17; 320(3)305-306. doi: 10.1001/jama.2018.5928.

PMID:
    30027241
    [PubMed - indexed for MEDLINE]
Related citations


Prevention of hospital-acquired pneumonia.
Lyons PG, Kollef MH
Curr Opin Crit Care. 2018 Oct; 24(5)370-378. doi: 10.1097/MCC.0000000000000523.

PMID:
    30015635
    [PubMed - in process]
Related citations


Using wearable technology to predict health outcomes: a literature review.
Burnham JP, Lu C, Yaeger LH, Bailey TC, Kollef MH
J Am Med Inform Assoc. 2018 Sep 1; 25(9)1221-1227. doi: 10.1093/jamia/ocy082.

PMID:
    29982520
    [PubMed - in process]
Related citations


Differences in mortality between infections due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Burnham JP, Kwon JH, Olsen MA, Babcock HM, Kollef MH
Infect Control Hosp Epidemiol. 2018 Sep; 39(9)1138-1139. doi: 10.1017/ice.2018.142.

PMID:
    29961440
    [PubMed - in process]
Related citations


The authors reply.
Roberts BW, Mohr NM, Ablordeppey E, Drewry AM, Ferguson IT, Trzeciak S, Kollef MH, Fuller BM
Crit Care Med. 2018 Jul; 46(7)e718-e719. doi: 10.1097/CCM.0000000000003110.

PMID:
    29912116
    [PubMed - in process]
Related citations


Acinetobacter Pneumonia: Improving Outcomes With Early Identification and Appropriate Therapy.
Vazquez Guillamet C, Kollef MH
Clin Infect Dis. 2018 Oct 15; 67(9)1455-1462. doi: 10.1093/cid/ciy375.

PMID:
    29741597
    [PubMed - in process]
Related citations


Clinical epidemiology of carbapenem-resistant gram-negative sepsis among hospitalized patients: Shifting burden of disease?
Britt NS, Ritchie DJ, Kollef MH, Burnham CD, Durkin MJ, Hampton NB, Micek ST
Am J Infect Control. 2018 Oct; 46(10)1092-1096. doi: 10.1016/j.ajic.2018.03.013.

PMID:
    29706365
    [PubMed - in process]
Related citations


Erratum for Drusano et al., "Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia".
Drusano GL, Corrado ML, Girardi G, Ellis-Grosse EJ, Wunderink RG, Donnelly H, Leeper KV, Brown M, Malek T, Hite RD, Ferrari M, Djureinovic D, Kollef MH, Mayfield L, Doyle A, Chastre J, Combes A, Walsh TJ, Dorizas K, Alnuaimat H, Morgan BE, Rello J, Mazo CA, Jones RN, Flamm RK, Woosley L, Ambrose PG, Bhavnani S, Rubino CM, Bulik CC, Louie A, Vicchiarelli M, Berman C
Antimicrob Agents Chemother. 2018 Apr; 62(4)pii: e00198-18. doi: 10.1128/AAC.00198-18.

PMID:
    29588353
    [PubMed - in process]
Related citations


Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections.
Burnham JP, Olsen MA, Stwalley D, Kwon JH, Babcock HM, Kollef MH
Open Forum Infect Dis. 2018 Mar; 5(3)ofy026. doi: 10.1093/ofid/ofy026.

PMID:
    29577058
    [PubMed]
Related citations


Frequent Versus Infrequent Monitoring of Endotracheal Tube Cuff Pressures.
Letvin A, Kremer P, Silver PC, Samih N, Reed-Watts P, Kollef MH
Respir Care. 2018 May; 63(5)495-501. doi: 10.4187/respcare.05926.

PMID:
    29382793
    [PubMed - indexed for MEDLINE]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2017:

Company Name: Merck

Royalties:

Equity: No

Consulting/Advisory Board: $1,000 - $10,000

Speaker Fees: $50,001 - $100,000

Reporting Date: May 01, 2018


Company Name: Allergan

Royalties:

Equity: No

Consulting/Advisory Board: $1 - $9,999

Speaker Fees: $40,000 - $59,999

Reporting Date: May 01, 2018


Company Name: Accelerate

Royalties:

Equity: No

Consulting/Advisory Board: $10,000 - $19,999

Speaker Fees:

Reporting Date: May 01, 2018


Company Name: Paratek Pharmaceuticals

Royalties:

Equity: No

Consulting/Advisory Board: $10,000 - $19,999

Speaker Fees:

Reporting Date: May 01, 2018